2013 / Meta-analysis of prospective studies
Tomato and lycopene consumption showed nonsignificant trends toward lower prostate cancer risk.
A meta-analysis evaluated 11 cohort and six nested case-control studies examining tomato and lycopene intake and prostate cancer risk. Higher intake of raw tomatoes (OR = 0.81; 95% CI, 0.59-1.10) and cooked tomatoes (OR = 0.85; 95% CI, 0.69-1.06) was not significantly associated with prostate cancer incidence compared to lower intake. Similarly, higher lycopene intake (OR = 0.93; 95% CI, 0.86-1.01) and serum lycopene (OR = 0.97; 95% CI, 0.88-1.08) showed no statistically significant associations.
Shows an association, not proof of cause and effect.
Chen J, Song Y, Zhang L J Nutr Sci Vitaminol (Tokyo), 2013. PMID 23883692